Non-Small Cell Lung Cancer - Global Clinical Trial Landscape (2024)

In 2022, there were an estimated 2.1 million cases of non-small cell lung cancer worldwide. However, new treatments in the pipeline could be the key to reducing its prevalence. Download the free report from leading CRO Novotech to get the latest insights on global clinical trials for non-small cell lung cancer, including emerging personalised treatments.